KeyBanc cuts FMC Corp stock price target to $51, maintains Overweight

On Tuesday, KeyBanc Capital Markets adjusted its outlook on FMC Corp (NYSE:FMC), a leading agricultural sciences company, by reducing the stock’s price target from $55.00 to $51.00, while still maintaining an Overweight rating on the shares. According to InvestingPro data, the stock has declined significantly over the past three months, with shares currently trading at a P/E ratio of 13.5x and offering a notable free cash flow yield of 13%.

The revision follows an assessment of the challenges FMC Corp faces as its diamides franchise transitions off-patent. KeyBanc analysts noted that the transition has begun unevenly, with generic versions of Rynaxypyr, a key product, entering some markets a year ahead of projections. Consequently, FMC Corp’s management is expediting its strategy to adapt to these changes. Despite these challenges, InvestingPro analysis indicates the company maintains a FAIR financial health score and has consistently paid dividends for 19 consecutive years.

Despite the anticipated turbulence in the upcoming quarters, KeyBanc remains optimistic about FMC Corp’s prospects. Their analysis suggests that there is a potential for share price appreciation over the next 12 to 24 months. The base case scenario indicates a 40% upside, whereas the downside scenario points to a 26% potential decline in share value. The firm acknowledges the current lack of visibility and the necessity for FMC Corp to regain investor confidence following a difficult fourth quarter. InvestingPro subscribers can access 10 additional key insights about FMC, including detailed valuation metrics and comprehensive financial health analysis in the Pro Research Report.

In addition to the company-specific factors, KeyBanc’s commentary also touched on the broader industry perspective, suggesting that the crop protection sector might be seeing an upturn. After what they believe was the bottom of the cycle, analysts expect an improvement in underlying demand over the coming quarters.

The price target adjustment reflects both the near-term challenges FMC Corp is facing with its product line and the broader market conditions that could influence the company’s performance moving forward.

In other recent news, FMC Corp. has experienced a series of notable developments. The company’s stock rating was downgraded to neutral by both Redburn-Atlantic and UBS, citing concerns over the risk-reward profile and potential long-term challenges, respectively. Jefferies, while maintaining a buy rating, reduced its price target for FMC Corp. based on a mixed financial outlook and anticipated sales headwinds.

In addition, FMC Corp. has extended the termination date of its $2.0 billion revolving credit facility by one year to June 17, 2028, as part of its strategy to secure long-term financial stability. This move enables the company to maintain its substantial credit line with its consortium of lenders and issuing banks.

Finally, FMC Corp. reported a fourth-quarter earnings per share (EPS) that exceeded the consensus, but its forecast for 2025 fell short of market expectations. The company’s lower guidance is attributed to several factors expected to impact sales and profitability. These developments reflect the ongoing changes and challenges in FMC Corp.’s business landscape.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.